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A
rmed with the power to 
prescribe, doctors are in a 
position to ﬂ  ood their patients’ 
bodies with potent medicines at a 
stroke of their pen—and they have 
been consistently wooed by the 
pharmaceutical industry. 
Doctors in Nepal have started to 
become targets for the pharmaceutical 
industry’s promotional activities. 
The mountainous, landlocked, 
developing country of Nepal, which 
has a population of about 23 million, 
has an annual per capita income, in 
terms of purchasing power parity, of 
about US$2,000 in urban areas and 
US$1,000 in rural areas. In Nepal, 
Western allopathic medicine coexists 
with traditional medical practices like 
Ayurveda, Tibetan medicine, and faith 
healing. Many rural areas lack access to 
modern health care, but Kathmandu 
and other cities are becoming booming 
markets for pharmaceuticals.
Pharmaceutical Promotion 
and Its Impact in Nepal
The promotional activities of medical 
representatives (MRs, also known 
as drug company representatives), 
and other promotional activities by 
pharmaceutical companies, have a 
major inﬂ  uence on prescribing and 
on drug use by the general public 
all over the world [1]. The World 
Health Organisation’s Department 
of Essential Drugs and Medicines 
Policy maintains a database of such 
promotional activities at http:⁄⁄
www.drugpromo.info. In Nepal, 
common prescribing problems are 
polypharmacy, and overprescription 
of antibiotics and injections [2]. We 
are studying prescribing patterns 
in our hospital and have observed 
excessive use of expensive antibiotics, 
vitamins, and digestive and enzyme 
preparations. The preparations 
prescribed are those that are 
actively promoted by MRs. I (PRS) 
have sometimes found consultants 
recommending to the hospital Drug 
and Therapeutics Committee that 
drugs of doubtful efﬁ  cacy be included 
in the hospital pharmacy, following 
visits by MRs. 
Most hospitals in Nepal allow free 
access of MRs to doctors, and academic 
detailing is absent. MRs bring with 
them many creative ideas for drug 
promotion. I (BRG) observed this 
for the ﬁ  rst time when I visited one 
of my professors. A signboard next to 
the door read “Doctor is IN-DIGENE” 
(Digene is a brand of antacid). After 
going inside, I noticed that there was 
at least one big poster promoting a 
pharmaceutical company on every 
wall. On the table was a beautifully 
handcrafted nameboard with the 
professor’s name in golden letters. 
The side facing the professor had the 
brand name of a drug in equally stylish 
lettering. 
Medical conferences in Nepal 
are strongly dominated by the 
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pharmaceutical industry. Often, 
companies organize parties for 
doctors in which a continuing 
medical education topic is followed 
by a lavish cocktail dinner—but often 
the educational part is absent. One 
such party was recently organized by 
a manufacturer of suture material 
and was attended by almost all the 
consultants and medical ofﬁ  cers of our 
hospital.
After doctors accept personal 
beneﬁ  ts from the industry, they 
might arguably feel an obligation to 
prescribe the promoted drug. There 
is certainly good evidence in the 
literature that such gifts from the 
industry are associated with changes 
in prescribing behavior (the evidence 
is collected at http:⁄⁄nofreelunch.
org/requiredinﬂ  uence.htm). 
Pharmaceutical companies also sponsor 
the activities of medical students (such 
sponsoring can take the form of sports 
matches, publications, and parties). 
The industry expects a substantial 
return for every rupee spent on doctors 
and medical students. 
Often, though, the cost of promotion 
is directly recovered from the patient. 
A lady I (BRG) knew once said to me, 
“I am taking only half the medicine. If 
it works well then I will get more. It is 
too expensive.” The tendency to buy a 
lesser amount of the drug or no drug at 
all is a common phenomenon in Nepal 
and leads to therapeutic failure. 
An Educational Initiative 
on Promotion
As a student at Manipal College 
of Medical Sciences (Figure 1), I 
(BRG) have had the opportunity to 
experience an educational initiative 
on drug companies’ promotional 
activities. This initiative involves small 
groups of students in interactive 
learning sessions. I have learned about 
common methods of drug promotion; 
unethical promotion practices; ways 
in which promotional materials give 
false impressions of the absolute and 
relative risks and the risk-beneﬁ  t ratio; 
and the interpretation of graphs used 
in advertisements and optimizing time 
spent with MRs.
Class activities include critical 
analysis of promotional material 
and drug advertisements against the 
World Health Organization’s Ethical 
Criteria for Medicinal Drug Promotion 
(http:⁄⁄www.who.int/medicines/
library/dap/ethical-criteria/ethicalen.
shtml). These criteria, prepared by 
an international group of experts, 
“constitute a frame of reference for 
judging proper behavior in drug 
promotion, whether involving the 
contents of advertisements and 
package inserts or the sponsorship 
of scientiﬁ  c symposia, and the use 
of representatives.” The criteria 
“give manufacturers, distributors, 
the promotion industry, prescribers 
and consumer groups a framework 
to ensure that promotional practices 
are in keeping with acceptable 
ethical standards.” Recently, role-play 
has been introduced into the class 
activities to present the interaction 
between a MR and a doctor. The 
interactions are critically analyzed 
by the groups. Students are assessed 
in critical analysis of promotional 
material during the pharmacology 
practical examinations. 
Prescribers often do not realize the 
inﬂ  uence of promotional materials 
and activities [3]. In our hospital, 
through the Drug Information Center, 
drug bulletin, and other measures, we 
are sensitizing prescribers to critically 
evaluate industry sources of drug 
information. Recognizing that it is 
easier to inculcate good prescribing 
habits in future doctors, teaching and 
learning about rational use of medicines 
and medicinal drug promotion are 
emphasized in the medical students’ 
pharmacology course. 
Impact of the Initiative
There has been a noticeable impact 
on the attitudes of medical students 
towards drug promotion. I (BRG) and 
my fellow students have been sensitized 
to the negative effects of aggressive 
promotion. In our hospital, aggressive 
promotion is evident but criticism 
is often difﬁ  cult to make. When I 
discussed this essay with an intern, 
he responded, “No MR will approach 
you. You will need them from your 
internship onwards.” 
I (PRS) am analyzing feedback 
obtained from a questionnaire about 
the educational initiatives. Preliminary 
assessment showed that students 
were favorably disposed toward and 
enjoyed the sessions. We are investing 
in the future, and believe that around 
10%–15% of our students have been 
convinced to take a hard, critical look 
at drug promotion. “Enlightened” 
students will be an important asset 
to their communities and countries. 
Long-term studies of the impact will be 
carried out in the future.
Conclusion 
The initiatives have helped me (BRG) 
critically analyze sources of information 
from the pharmaceutical industry. In 
the future, I am conﬁ  dent that I will 
be prepared for the sales pitches and 
gimmicks of the industry.
When prescribers are made 
aware of the methods used by drug 
promoters, it is more difﬁ  cult for 
unhealthy practices to take root; the 
ultimate beneﬁ  ciaries are the patient 
and the community. We (PRS and 
colleagues) plan to bring in actual 
MRs to demonstrate the promotional 
techniques and to show videotaped 
encounters between doctors and MRs. 
We plan to strengthen the role-plays 
in the future. We are trying to enlist 
the support of the hospital’s Drug and 
Therapeutics Committee to conduct 
sessions on drug promotion for the 
interns and medical ofﬁ  cers.  
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